Overall, the findings establish that ABCC6 plays a crucial role in modulating plasma lipoproteins and the hapolinsufficient development of atherosclerosis, with implications for understanding the cardiovascular risks associated with ABCC6 mutations. The gene discussed is ABCC6; the disease is atherosclerosis.